Company Management

株式会社ヘリオス

Biotechnology Research Tokyo, Tôkyô, Jp 29 employees

Employees: 29
Contacts: 1
Emails: 1

healios.co.jp LinkedIn Crunchbase

株式会社ヘリオス Overview

Headquarters: Tokyo, Tôkyô, Jp
Phone Number: Available in AeroLeads
Website: healios.co.jp
Industry: Biotechnology Research
Employees: 29
Founded: 2011
Funding: 30.9M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

iPS バイオベンチャー MultiStem Stem cell 再生医療再生医薬品マザーズ

About 株式会社ヘリオス

弊社は、バイオ革命によって急速に発展し始めている再生医療分野において、体性幹細胞再生医薬品/iPSC再生医薬品の研究開発を行っているバイオベンチャーです。2015年6月には東証マザーズに上場。再生・細胞医薬品の開発・製造を世界で先駆けて取り組み、病で苦しむ患者さんに治療法を提供し希望を届けることを目標としています。 Our company is a bio venture which is doing R & D of somatic stem cell regenerating medicine / iPSC regenerating medicine in the regenerative medicine field which is rapidly developing by the bio-revolution. We were listed on TSE Mothers in June 2015. Our long-term object is to deliver hope to patients suffering from illness by providing treatment methods by pioneering the development and manufacture of regeneration and cellular medicines worldwide.

株式会社ヘリオス Contact Details

People in AeroLeads: 3
With contact data: 1
Email contacts: 1; 33.3% coverage

株式会社ヘリオス Org Chart

Sample employees and titles

Name	Title	Location	Contact
Dr. Tadahisa "Hardy" Kagimoto, Md	Founder, Chairman and CEO of Healios K.k. Founder, Chairman of Power X		View
Shota Shimizu	Regenerative Medicine		View
Hiromu Ozaki	Eva Therapeutics, Inc. - Chief Executive Officer; Yakumed, Ltd. - Japan Representative	Osaka, Japan	Email